Development of memory-enhancing agents in the treatment of Alzheimer's disease.
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D008568:Memory / Q000187:drug effects*; D018377:Neurotransmitter Agents / Q000627:therapeutic use; D013619:Tacrine / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D018377:Neurotransmitter Agents; D013619:Tacrine